Results 31 to 40 of about 1,487,242 (142)

Sydrome de Marcus-Gunn: à propos d'un cas

open access: yesThe Pan African Medical Journal, 2016
Le syndrome de Marcus Gunn est un syndrome qui associe un ptosis congénital et une syncinésie mandibulo-palpébrale lors de certains mouvements mandibulaires.
Rajaa Elhannati   +3 more
doaj   +1 more source

Marcus Gunn Jaw Winking Syndrome in a 60-Year-Old Male - A Rare Case Report

open access: yesJournal of Indian Academy of Oral Medicine and Radiology
Marcus Gunn jaw-winking syndrome (MGJWS) is a rare congenital cranial dysinnervation disorder that causes eyelid ptosis during jaw movement, usually seen in childhood.
Ramachandra Reddy Gowda Venkatesha   +3 more
doaj   +1 more source

Paralisia facial periférica idiopática de Bell: a propósito de 180 pacientes Idiopathic facial paralysis (Bell´s palsy): a study of 180 patients

open access: yesArquivos de Neuro-Psiquiatria, 2001
O objetivo deste estudo foi analisar aspectos clínicos, epidemiológicos e evolutivos da paralisia facial periférica idiopática em 180 pacientes. Houve ligeiro predomínio do sexo feminino (66,7%).
Marcelo Moraes Valença   +2 more
doaj   +1 more source

Brown syndrome associated with Marcus-Gunn jaw winking ptosis

open access: yes, 2018
Brown syndrome is a rare mechanical disorder characterized by restriction of the superior oblique trochlea-tendon complex.  Marcus-Gunn jaw winking ptosis is a more common congenital oculofacial synkinesis in which blepharoptosis is associated with upper
Rizzo, Stanislao   +3 more
core   +1 more source

Electronically tuned 23 GHz Gunn oscillators for a microwave datalink [PDF]

open access: yes, 1988
Includes bibliographical references.A market has been identified for 23 GHz, short-haul, low-capacity, digital radio. The dissertation presents the development of the varactor controlled Gunn oscillators that constitute the crystal locked microwave ...
Kratzenstein, L
core   +1 more source

Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale

open access: yesAnnals of Neurology, Volume 99, Issue 4, Page 949-963, April 2026.
Objective Dopaminergic imaging is a key biomarker for both the investigation of the biology of Parkinson's disease and related synucleinopathies and the evaluation of potential therapies in clinical trials. This work presents a harmonized approach for quantifying dopaminergic molecular imaging tracers, such as [123I]ioflupane (dopamine transporter scan
Zhen Fan   +174 more
wiley   +1 more source

Ultrasound biomicroscopy image patterns in normal upper eyelid and congenital ptosis in the Indian population

open access: yesIndian Journal of Ophthalmology, 2018
Purpose: To study the features of upper eyelid in healthy individual and different types of congenital ptosis in the Indian population using ultrasound biomicroscopy (UBM).
Abhidnya Surve   +3 more
doaj   +1 more source

Speech and Language Disorders Associated With 7q31 Deletions Implicating FOXP2

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 12, December 2025.
ABSTRACT Some 7q31 deletions encompass FOXP2, a gene long associated with speech and language disorders. Intragenic pathogenic FOXP2 variants cause FOXP2‐related speech and language disorder, which has been well characterized in the literature. Conversely, the phenotype associated with 7q31 deletions is neglected.
Lottie D. Morison   +3 more
wiley   +1 more source

PET‐measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations

open access: yesAlzheimer's &Dementia, Volume 21, Issue 6, June 2025.
Abstract INTRODUCTION Individuals with Down syndrome (DS) have a high prevalence of Alzheimer's disease (AD) and reveal an earlier age of amyloid beta (Aβ) onset compared to sporadic AD. Differences in amyloid accumulation rates between DS and sporadic AD populations have not been established. METHODS Participants with ≥ 3 [C‐11]PiB scans (spanning > 6
Andrew McVea   +24 more
wiley   +1 more source

Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background In patients receiving anti‐cancer treatment, cachexia results in poorer oncological outcomes. However, there is limited understanding and no systematic review of oncological endpoints in cancer cachexia (CC) trials. This review examines oncological endpoints in CC clinical trials.
Olav Dajani   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy